Is it always necessary to perform an axillary lymph node dissection on patients undergoing neoadjuvant therapy? Outcomes of a retrospective study.
CONCLUSIONS: The possibility to detect patients with a lower risk of nodal disease before surgery may reduce the rate of false negative results of sentinel lymph node biopsy in patients receiving a neoadjuvant therapy.
KEY WORDS: Axilla, Breast cancer, Lymphnodes, Lymphonodes sentinel.
PMID: 31657352 [PubMed - in process]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery